NCT02587416View on ClinicalTrials.gov

Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions
Hypercholesteremia
Interventions
DRUG

Gemcabene 300 mg

1x300 mg gemcabene tablets orally once daily (QD) for 11 days

DRUG

Gemcabene 900 mg

3x300 mg Gemcabene tablets orally once daily (QD) for 11 days

DRUG

Atorvastatin

2x40 mg Atorvastatin tablets orally once daily (QD)

Sponsors
All Listed Sponsors
lead

NeuroBo Pharmaceuticals Inc.

INDUSTRY